Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
Equities
688621
CNE100005139
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.45 CNY | +1.26% | +3.73% | -16.20% |
Sales 2024 * | 1.26B 174M 239M | Sales 2025 * | 1.65B 229M 313M | Capitalization | 6.55B 906M 1.24B |
---|---|---|---|---|---|
Net income 2024 * | 277M 38.34M 52.47M | Net income 2025 * | 388M 53.71M 73.5M | EV / Sales 2024 * | 5.2 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.96 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
14.7
x | Employees | 1,126 |
Yield 2024 * |
1.18% | Yield 2025 * |
1.56% | Free-Float | 52.15% |
1 day | +1.26% | ||
1 week | +3.73% | ||
Current month | +3.73% | ||
1 month | -9.10% | ||
3 months | -11.71% | ||
6 months | -15.63% | ||
Current year | -16.20% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Liu
CEO | Chief Executive Officer | 42 | 09-02-28 |
Ling Yang Zhao
DFI | Director of Finance/CFO | 36 | 20-03-20 |
Ming Juan Wang
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qian Li
CHM | Chairman | 43 | 09-03-08 |
Qiao Chen
BRD | Director/Board Member | 44 | 20-03-20 |
Zhuang Kun He
BRD | Director/Board Member | 52 | 20-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 58.45 | +1.26% | 1,568,796 |
24-05-08 | 57.72 | -1.05% | 1,373,555 |
24-05-07 | 58.33 | -1.03% | 1,423,705 |
24-05-06 | 58.94 | +4.60% | 2,082,610 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.20% | 907M | |
+23.37% | 47.02B | |
+49.96% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- 688621 Stock